This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Hitting New Highs Today

Ariad Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Ariad Pharmaceuticals (ARIA - Get Report) is a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level. This stock is trading up 2.8% at $13.59 in recent trading after hitting a 52-week high of $13.66 earlier in the day.

Today's Range: $13.20-$13.66

52-week Range: $5.06-$13.50

Volume: 1.8 million

Three-Month Average Volume: 3.15 million

Ariad Pharmaceuticals has a market cap of $1.80 billion and an enterprise value of $1.68 billion. The stock trades at a price-to-sales of 68.13 and a price-to-book of 65.40. Its estimated growth rate for this year is 134.5%, and for next year it's pegged at 19.4%. The current short interest as a percentage of the float for Ariad Pharmaceuticals stands at 12.8%.

From a technical standpoint, ARIA recently triggered a breakout trade when the stock took out some past overhead resistance at $12.50 with solid volume. The stock is now triggering another big breakout trade, with shares moving above some major overhead resistance from July at $13.50.

Traders should now look for a sustained high-volume move and close above $13.50 to signal that ARIA wants to trend significantly higher. Look for volume that's near or above its average action of 3.15 million shares.

Ariad shows up on a list of 10 Biotech Stocks Loved and Hated by Wall Street's Top Investment Pros for the most recently reported quarter.
5 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
ARIA $7.78 -5.40%
ALXN $198.51 -2.50%
BMRN $144.29 -1.10%
HUM $184.38 -0.08%
NWSA $14.84 0.34%


Chart of I:DJI
DOW 17,751.39 +121.12 0.69%
S&P 500 2,108.57 +15.32 0.73%
NASDAQ 5,111.7330 +22.5270 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs